Skip to main content
Top
Published in: Archives of Virology 3/2018

01-03-2018 | Original Article

Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains

Authors: Junpei Hara, Yuka Tanaka, Hiroto Kaneko, Yoshito Itoh, Hiroshi Ikegaya

Published in: Archives of Virology | Issue 3/2018

Login to get access

Abstract

A large number of accidental virus infections occur in medical and non-medical workers exposed to infectious individuals and materials. We evaluated whether postmortem blood and bloodstains containing hepatitis B virus (HBV) are infectious. HBV-infected blood and bloodstains were stored for up to 60 days at room temperature and subsequently screened for hepatitis B surface antigen (HBsAg) and HBV DNA. In addition, HBV-positive postmortem blood was added to a cell line and the production of HBV virions was examined over a period of 7 days. HBsAg and HBV DNA were detected in all samples stored for 60 days at room temperature. HBV-positive postmortem blood successfully infected the cell line and progeny viruses were produced for up to 6 days. Thus, it is crucial that due care is taken when handling not only living material infected with HBV, as well as other harmful viruses, but also blood or body fluids from cadavers or medical waste.
Literature
1.
go back to reference Victory KR, Coronado F, Ifono SO, Soropogui T, Dahl BA, Centers for Disease Control and Prevention (CDC) (2015) Ebola transmission linked to a single traditional funeral ceremony—Kissidougou, Guinea, December 2014-January 2015. MMWR Morb Mortal Wkly Rep 64:386–388PubMed Victory KR, Coronado F, Ifono SO, Soropogui T, Dahl BA, Centers for Disease Control and Prevention (CDC) (2015) Ebola transmission linked to a single traditional funeral ceremony—Kissidougou, Guinea, December 2014-January 2015. MMWR Morb Mortal Wkly Rep 64:386–388PubMed
2.
go back to reference Yanagi M (2016) The group infection of tuberculosis. Doctors in The University of Tokyo were also infected. The Mainichi (In Japanese) Yanagi M (2016) The group infection of tuberculosis. Doctors in The University of Tokyo were also infected. The Mainichi (In Japanese)
3.
go back to reference Takasaka T, Itoh Y, Kaneko H, Ikegaya H (2011) Detection of hepatitis C virus and antibodies in postmortem blood and bloodstains. J Clin Microbiol 49:1122–1123CrossRefPubMedPubMedCentral Takasaka T, Itoh Y, Kaneko H, Ikegaya H (2011) Detection of hepatitis C virus and antibodies in postmortem blood and bloodstains. J Clin Microbiol 49:1122–1123CrossRefPubMedPubMedCentral
4.
go back to reference Ramirez S, Mikkelsen LS, Gottwein JM, Bukh J (2016) Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir. Gastroenterology 151:973–985CrossRefPubMed Ramirez S, Mikkelsen LS, Gottwein JM, Bukh J (2016) Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir. Gastroenterology 151:973–985CrossRefPubMed
5.
go back to reference Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212–2219CrossRefPubMed Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212–2219CrossRefPubMed
6.
go back to reference Lavanchy D (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34(Suppl 1):S1–S3CrossRefPubMed Lavanchy D (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34(Suppl 1):S1–S3CrossRefPubMed
7.
go back to reference Coppola N, De Pascalis S, Onorato L, Calò F, Sagnelli C, Sagnelli E (2016) Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol 8:273–281CrossRefPubMedPubMedCentral Coppola N, De Pascalis S, Onorato L, Calò F, Sagnelli C, Sagnelli E (2016) Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol 8:273–281CrossRefPubMedPubMedCentral
8.
go back to reference Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005–1009CrossRefPubMedPubMedCentral Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005–1009CrossRefPubMedPubMedCentral
9.
go back to reference Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW (1997) Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41:1715–1720PubMedPubMedCentral Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW (1997) Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41:1715–1720PubMedPubMedCentral
10.
go back to reference Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH (1999) Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 450:66–71CrossRefPubMed Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH (1999) Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 450:66–71CrossRefPubMed
12.
go back to reference Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC (1993) Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 153:1705–1712CrossRefPubMed Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC (1993) Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 153:1705–1712CrossRefPubMed
13.
go back to reference Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K, Japanese Red Cross NAT Screening Research Group (2005) Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 88:10–16CrossRefPubMed Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K, Japanese Red Cross NAT Screening Research Group (2005) Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 88:10–16CrossRefPubMed
14.
go back to reference Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group (2005) Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366:1379–1384CrossRefPubMed Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group (2005) Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366:1379–1384CrossRefPubMed
15.
go back to reference US Public Health Service (2001) Updated US public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm 50 (RR-11), pp 1–52 US Public Health Service (2001) Updated US public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm 50 (RR-11), pp 1–52
16.
go back to reference Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266–6273CrossRefPubMed Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266–6273CrossRefPubMed
17.
go back to reference Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E, National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group (2008) Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 46:868–875CrossRefPubMed Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E, National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group (2008) Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 46:868–875CrossRefPubMed
18.
go back to reference Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1:e00049CrossRefPubMedPubMedCentral Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1:e00049CrossRefPubMedPubMedCentral
19.
go back to reference Kullak-Ublick GA, Ismair MG, Kubitz R, Schmitt M, Häussinger D, Stieger B, Hagenbuch B, Meier PJ, Beuers U, Paumgartner G (2000) Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells. Cytotechnology 34:1–9CrossRefPubMedPubMedCentral Kullak-Ublick GA, Ismair MG, Kubitz R, Schmitt M, Häussinger D, Stieger B, Hagenbuch B, Meier PJ, Beuers U, Paumgartner G (2000) Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells. Cytotechnology 34:1–9CrossRefPubMedPubMedCentral
20.
go back to reference Neurath AR, Kent SB, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429–436CrossRefPubMed Neurath AR, Kent SB, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429–436CrossRefPubMed
21.
go back to reference Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P (1991) HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1 (21–47). Virology 180:483–491CrossRefPubMed Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P (1991) HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1 (21–47). Virology 180:483–491CrossRefPubMed
22.
go back to reference Qiao M, Macnaughton TB, Gowans EJ (1994) Adsorption and penetration of hepatitis B virus in a nonpermissive cell line. Virology 201:356–363CrossRefPubMed Qiao M, Macnaughton TB, Gowans EJ (1994) Adsorption and penetration of hepatitis B virus in a nonpermissive cell line. Virology 201:356–363CrossRefPubMed
Metadata
Title
Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains
Authors
Junpei Hara
Yuka Tanaka
Hiroto Kaneko
Yoshito Itoh
Hiroshi Ikegaya
Publication date
01-03-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3665-x

Other articles of this Issue 3/2018

Archives of Virology 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.